Synthesis, molecular modeling and bioevaluation of new benzimidazole derivatives as dual KSP (Kinesin Spindle Protein) and Aurora A Kinase inhibitors for antitumor activity
DOI:
https://doi.org/10.56511/JIPBS.2017.v4.i02.pp17-27Abstract
A series of dioxopyrimido[2,1-b][1,3]thiazine derivatives (3a-f,6a-e ) has been synthesized and their biological activities were also evaluated as potential dual KSP and Aurora A Kinase inhibitors. Bioassay tests demonstrated that most of the compounds exhibited substantial broad-spectrum antitumor activity against the seven cancer cell lines (HepG2, SNB19, HT29, K562, A549-ATCC, MDA-MB-435 and SKOV3). Moreover, all the title compounds were assayed for as dual KSP and Aurora A kinase inhibition using the MT-activated ATPase assay. Compound (6b) displayed the most potent anticancer activities, which was comparable to the positive control and Molecular modeling has been done for this compound. The results may be used for developing a new class of inhibitors having a dual roles, KSP inhibition and Aurora-A kinase inhibition for the treatment of cancer.
Keywords:
Benzimidazole, Human cancer cells, Aurora A Kinase, KSP inhibition, Dioxopyrimido [2, 1-b] [1,3] ThiazineDownloads
References
Lawrence, C. J.; Dawe, R. K.; Christie, K. R.; Cleveland, D. W.; Dawson, S. C.; Endow, S. A.; Goldstein, L. S.; Goodson, H. V.; Hirokawa, N.; Howard, J.; Malmberg, R. L.; McIntosh, J. R.; Miki, H.; Mitchison, T. J.; Okada, Y.; Reddy, A.S.; Saxton, W. M.; Schliwa, M.; Scholey, J. M.; Vale, R. D.; Walczak, C. E.; Wordeman, L. J: A standardized kinesin nomenclature. Cell Biol. 2004; 167(1):19-22.
Mayer, T. U.; Kapoor, T. M.; Haggarty, S. J.; King, R. W.; Schreiber, S. L.; Mitchison, T. J: Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen. Science 1999; 286(5441): 971-974.
Lad, L.; Luo, L.; Carson, J. D.; Wood, K. W.; Hartman, J. J.; Copeland, R. A.; Sakowicz, R: Mechanism of Inhibition of Human KSP by Ispinesib. Biochemistry 2008; 47(11):3576-3585.
Sakowicz, R.; Finer, J. T.; Beraud, C.; Crompton, A.; Lewis, E.; Fritsch, A.; Lee, Y.; Mak, J.; Moody, R.; Turincio, R.; Chabala, J. C.; Gonzales, P.; Roth, S.; Weitman, S.; Wood, K. W: Antitumor Activity of a Kinesin Inhibitor. Cancer Res. 2004; 64(9):3276-3280.
Woessner, R.; Tunquist, B.; Lemieux, C.; Chlipala, E.; Jackinsky, S.; Dewolf, W., Jr.; Voegtli, W.; Cox, A.; Rana, S.; Lee, P.; Walker, D: 447 POSTER ARRY-520, a KSP inhibitor with potent in vitro and in vivo efficacy and pharmacodynamic activity in models of multiple myeloma. European Journal of Cancer Supplements 2008; 6(12):140-141.
Huszar, D.; Theoclitou, M. E.; Skolnik, J.; Herbst, R: Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev. 2009; 28 (1-2):197-208.
Yang, L.; Jiang, C.; Liu, F.; You, Q. D.; Wu, W. T: Cloning, Enzyme Characterization of Recombinant Human Eg5 and the Development of a New Inhibitor. Biol. Pharm. Bull. 2008; 31(7):1397-1402.
Garuti, L.; Roberti, M.; Bottegoni, G: Small Molecule Aurora Kinases Inhibitors. Curr. Med. Chem. 2009; 16(16):1949-1963.
Bavetsias, V.; Sun, C.; Bouloc, N.; Reynisson, J.; Workman, P.; Linardopoulos, S.; McDonald, E: Hit generation and exploration: Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases. Bioorg. Med. Chem. Lett. 2007; 17(23):6567-6571.
Moriarty, K. J.; Koblish, H. K.; Garrabrant, T.; Maisuria, J.; Khalil, E.; Ali, F.; Petrounia, I. P.; Crysler, C. S.; Maroney, A. C.; Johnson, D. L.; Galemmo, R. A., Jr: The synthesis and SAR of 2-amino-pyrrolo[2,3d]pyrimidines: A new class of Aurora-A kinase inhibitors. Bioorg. Med. Chem. Lett. 2006; 16(22):5778-5783.
Harrington, E. A.; Bebbington, D.; Moore, J.; Rasmussen, R. K.; AjoseAdeogun, A. O.; Nakayama, T.; Graham, J. A.; Demur, C.; Hercend, T.; Diu-Hercend, A.; Su, M.; Golec, J. M.; Miller, K. M: VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat. Med. 2004; 10(3):262-267.
Fabian, M. A.; Biggs, W. H.; Treiber, D. K.; Zarrinkar, P.P.; Lockhart D.J: Response to Molecule – kinase interaction map. Nature Biotechnology 2005; 23(11):1346-1348.
Giet, R.; Uzbekov, R.; Cubizolles, F.; Le Guellec, K.; Prigent, C. J: The Xenopus laevis Aurora-related Protein Kinase pEg2 Associates with and Phosphorylates the Kinesin-related Protein XlEg5. Biol. Chem. 1999; 274(21):1500515013.
Liu, F.; You, Q. D.; Chen, Y. D: Pharmacophore identification of KSP inhibitors. Bioorg. Med. Chem. Lett. 2007; 17(3):722-726.
Jiang, C.; You, Q.; Liu, F.; Wu, W.; Guo, Q.; Chern, J.; Yang, L.; Chen, M: Design, Synthesis and Evaluation of Tetrahydroisoquinolines as New Kinesin Spindle Protein Inhibitors. Chem. Pharm. Bull. Tokyo 2009; 57(6):567-571.
Shaabani, A.; Rahmati, A.; Naderi, S: A novel one-pot three-component reaction: Synthesis of triheterocyclic 4H-pyrimido[2,1-b]benzazoles ring systems. Bioorg. Med. Chem. Lett. 2005; 15(24):55535557.
Yao, C. S.; Lei, S.; Wang, C. H.; Yu, C. X.; Shao, Q. Q.; Tu, S. J: Onepot Three-component Solvent-free Synthesis of Benzo[4,5]imidazo[1,2a]pyrimidine Derivatives Catalyzed by Sulfamic Acid.Chinese J. Chem. 2008; 26(11):2107-2111.
Yao, C.; Lei, S.; Wang, C.; Li, T.; Yu,C.; Wang, X.; Tu, S.: ChemInform Abstract: Three-Component Synthesis of 4-Aryl-1H-pyrimido[1,2a]benzimidazole Derivatives in Ionic Liquid. ChemInform 2010; 41(24).
Lewandowski, K.; Murer, P.; Svec, F.; Frechet, J. M. J: A Combinatorial Approach to Recognition of Chirality: Preparation of Highly Enantioselective Aryl-Dihydropyrimidine Selectors for Chiral HPLC. Comb. Chem. 1999; 1(1):105-112.
Morgans, A.K.; Smith, M.R: Current Clinical Urology, Pitfalls of Androgen Deprivation Therapy, Edt. Klein, E.A.; Jones, J.S.; Humana Press, USA, 2013; 13: 79-400.
Abd El-All, A. S.; Ragab, F.A.F.; Magd El-Din, A.A.; Abdalla, M.M.; ElHefnawi, M. M.; El-Rashedy, A.A.: Design, Synthesis and Anticancer Evaluation of Some Selected Schiff Bases Derived from Benzimidazole Derivative. Global Journal of Pharmacology 2013; 7(2): 143-152.
Abd El-All, A. S.; Magd-El-Din, A.A.; Ragab, F.A.F.; El-Hefnawi, M.; Abdalla, M.M.; Galal, S.A.; El-Rashedy, A. A: New Benzimidazoles and Their Antitumor Effects with Aurora A Kinase and KSP Inhibitory Activities. Arch. Pharm. Chem. Life Sci. 2015; 348(7):475-486.
Mosmann, T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983; 65(1-2):55-63.
Risley, V. A.; Henry, S.; Kosyrikhina, M. V.; Manzanares, M. R.; Payan, I.; Downer, C. D.; Hellmann, C. C.; Van Slambrouck, S.; Frolova, L. V: 4-Amino-2-Aryl-3-Cyano1,2Dihydropyrimido- [1,2-a] Benzimidazoles AND their Pyrimidine Analogs as New Anticancer Agents. Chemistry of Heterocyclic Compounds 2014; 50(2):185-194.
Published
How to Cite
Issue
Section
Copyright (c) 2017 Asmaa A. Magd El-Din, Weam. S. El-serwy, Amira S. Abd El-All, N.M.A .El-Ebrashi, Mohamed M. Abdalla, Ahmed A. El-Rashedy
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at